Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia

References

• Vardiman JW , Thiele J , Arber DA , et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood . 2009;114(5):937–951. doi:10.1182/blood-2009-03-209262 19357394
   PubMed Web of Science ®Google Scholar
• Wang ZY , Chen Z . Acute promyelocytic leukemia: from highly fatal to highly curable. Blood . 2008;111(5):2505–2515. doi:10.1182/blood-2007-07-102798 18299451
   PubMed Web of Science ®Google Scholar
• Norgaard JM , Friis LS , Kristensen JS , et al. Addressing the room for improvement in management of acute promyelocytic leukemia. Eur J Haematol . 2019;102(6):479–485. doi:10.1111/ejh.13229 30887583
   PubMed Web of Science ®Google Scholar
• Zhu HH . The history of the chemo-free model in the treatment of acute promyelocytic leukemia. Front Oncol . 2020;10:592996. doi:10.3389/fonc.2020.592996 33304850
   PubMed Web of Science ®Google Scholar
• Coombs CC , Tavakkoli M , Tallman MS . Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer J . 2015;5(4):e304. doi:10.1038/bcj.2015.25 25885425
   PubMed Web of Science ®Google Scholar
• Sanz MA , Montesinos P . Advances in the management of coagulopathy in acute promyelocytic leukemia. Thromb Res . 2020;191(Suppl 1):S63–S67. doi:10.1016/S0049-3848(20)30399-6 32736781
   PubMed Web of Science ®Google Scholar
• Powell BL , Moser B , Stock W , et al. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood . 2010;116(19):3751–3757. doi:10.1182/blood-2010-02-269621 20705755
   PubMed Web of Science ®Google Scholar
• Sanz MA , Montesinos P , Rayon C , et al. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood . 2010;115(25):5137–5146. doi:10.1182/blood-2010-01-266007 20393132
   PubMed Web of Science ®Google Scholar
• Avvisati G , Lo-Coco F , Paoloni FP , et al. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood . 2011;117(18):4716–4725. doi:10.1182/blood-2010-08-302950 21385856
   PubMed Web of Science ®Google Scholar
• Ades L , Guerci A , Raffoux E , et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL group experience. Blood . 2010;115(9):1690–1696. doi:10.1182/blood-2009-07-233387 20018913
   PubMed Web of Science ®Google Scholar
• Mantha S , Tallman MS , Devlin SM , et al. Predictive factors of fatal bleeding in acute promyelocytic leukemia. Thromb Res . 2018;164(Suppl 1):S98–S102. doi:10.1016/j.thromres.2018.01.038 29703492
   PubMed Web of Science ®Google Scholar
• Tallman MS , Andersen JW , Schiffer CA , et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood . 2002;100(13):4298–4302. doi:10.1182/blood-2002-02-0632 12393590
   PubMed Web of Science ®Google Scholar
• Yanada M , Matsushita T , Asou N , et al. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. Eur J Haematol . 2007;78(3):213–219. doi:10.1111/j.1600-0609.2006.00803.x 17241371
   PubMed Web of Science ®Google Scholar
• Zhang Y , Hou W , Wang P , et al. Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death. Cancer Manag Res . 2018;10:3619–3627. doi:10.2147/CMAR.S167686 30271210
   PubMed Web of Science ®Google Scholar
• Naymagon L , Mascarenhas J . Hemorrhage in acute promyelocytic leukemia: can it be predicted and prevented? Leuk Res . 2020;94:106356. doi:10.1016/j.leukres.2020.106356 32445941
   PubMed Web of Science ®Google Scholar
• Hou J , Wang S , Zhang Y , et al. Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide. Ann Hematol . 2017;96(12):2005–2013. doi:10.1007/s00277-017-3130-7 28940056
   PubMed Web of Science ®Google Scholar
• Zhao H , Zhao Y , Zhang Y , et al. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia. Ann Hematol . 2018;97(3):409–416. doi:10.1007/s00277-017-3216-2 29289982
   PubMed Web of Science ®Google Scholar
• Mantha S , Goldman DA , Devlin SM , et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood . 2017;129(13):1763–1767. doi:10.1182/blood-2016-10-747170 28082441
   PubMed Web of Science ®Google Scholar
• de la Serna J , Montesinos P , Vellenga E , et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood . 2008;111(7):3395–3402. doi:10.1182/blood-2007-07-100669 18195095
   PubMed Web of Science ®Google Scholar
• McClellan JS , Kohrt HE , Coutre S , et al. Treatment advances have not improved the early death rate in acute promyelocytic leukemia. Haematologica . 2012;97(1):133–136. doi:10.3324/haematol.2011.046490 21993679
   PubMed Web of Science ®Google Scholar
• Park JH , Qiao B , Panageas KS , et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood . 2011;118(5):1248–1254. doi:10.1182/blood-2011-04-346437 21653939
   PubMed Web of Science ®Google Scholar
• Bai Y , Shi M , Yang X , et al. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis. Leuk Res . 2019;79:34–37. doi:10.1016/j.leukres.2019.02.007 30831481
   PubMed Web of Science ®Google Scholar
• Sanz MA , Lo CF , Martin G , et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood . 2000;96(4):1247–1253.10942364
   PubMed Web of Science ®Google Scholar
• Sanz MA , Fenaux P , Tallman MS , et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood . 2019;133(15):1630–1643. doi:10.1182/blood-2019-01-894980 30803991
   PubMed Web of Science ®Google Scholar
• Testi AM , Pession A , Diverio D , et al. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood . 2018;132(4):405–412. doi:10.1182/blood-2018-03-836528 29789356
   PubMed Web of Science ®Google Scholar
• Minamiguchi H , Fujita H , Atsuta Y , et al. Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia. Ann Hematol . 2020;99(12):2787–2800. doi:10.1007/s00277-020-04245-6 32879992
   PubMed Web of Science ®Google Scholar
• Hou W , Zhang Y , Jin B , et al. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone. Blood Cells Mol Dis . 2019;79:102351. doi:10.1016/j.bcmd.2019.102351 31400712
   PubMed Web of Science ®Google Scholar
• Abla O , Ribeiro RC , Testi AM , et al. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Ann Hematol . 2017;96(9):1449–1456. doi:10.1007/s00277-017-3042-6 28597167
   PubMed Web of Science ®Google Scholar
• Song YH , Peng P , Qiao C , et al. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia. Onco Targets Ther . 2017;10:4917–4924. doi:10.2147/OTT.S144438 29062237
   PubMed Web of Science ®Google Scholar
• Mitrovic M , Suvajdzic N , Bogdanovic A , et al. International society of thrombosis and hemostasis scoring system for disseminated intravascular coagulation >/= 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia. Med Oncol . 2013;30(1):478.23371042
   PubMed Web of Science ®Google Scholar
• Chang H , Kuo MC , Shih LY , et al. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Eur J Haematol . 2012;88(4):321–328. doi:10.1111/j.1600-0609.2011.01747.x 22221178
   PubMed Web of Science ®Google Scholar
• Dally N , Hoffman R , Haddad N , et al. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. Thromb Res . 2005;116(2):109–114. doi:10.1016/j.thromres.2004.11.001 15907524
   PubMed Web of Science ®Google Scholar
• Naymagon L , Moshier E , Tremblay D , et al. Predictors of early hemorrhage in acute promyelocytic leukemia. Leuk Lymphoma . 2019;60(10):2394–2403. doi:10.1080/10428194.2019.1581187 30849255
   PubMed Web of Science ®Google Scholar
• Rodeghiero F , Avvisati G , Castaman G , et al. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood . 1990;75(11):2112–2117. doi:10.1182/blood.V75.11.2112.2112 2189506
   PubMed Web of Science ®Google Scholar
• Breccia M , Latagliata R , Cannella L , et al. Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation. Haematologica . 2010;95(5):853–854. doi:10.3324/haematol.2009.017962 20015875
   PubMed Web of Science ®Google Scholar
• Kim DY , Lee JH , Lee JH , et al. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia. Leuk Res . 2011;35(2):152–158. doi:10.1016/j.leukres.2010.05.022 20554322
   PubMed Web of Science ®Google Scholar
• Chu T , Wang H , Lv X , et al. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia. Platelets . 2020; 1–7. doi:10.1080/09537104.2020.1799969
   Web of Science ®Google Scholar
• Ikezoe T . Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol . 2014;100(1):27–37. doi:10.1007/s12185-013-1463-0 24217998
   PubMed Web of Science ®Google Scholar
• Liu Y , Wang Z , Jiang M , et al. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk Res . 2011;35(7):879–884. doi:10.1016/j.leukres.2010.11.008 21146216
   PubMed Web of Science ®Google Scholar
• Yan J , Wang K , Dong L , et al. PML/RARalpha fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association. Proc Natl Acad Sci U S A . 2010;107(8):3716–3721. doi:10.1073/pnas.0915006107 20133705
   PubMed Web of Science ®Google Scholar
• Zhu J , Guo WM , Yao YY , et al. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia . 1999;13(7):1062–1070. doi:10.1038/sj.leu.2401448 10400422
   PubMed Web of Science ®Google Scholar
• Menell JS , Cesarman GM , Jacovina AT , et al. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med . 1999;340(13):994–1004. doi:10.1056/NEJM199904013401303 10099141
   PubMed Web of Science ®Google Scholar
• Kaufman RM , Djulbegovic B , Gernsheimer T , et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med . 2015;162(3):205–213. doi:10.7326/M14-1589 25383671
   PubMed Web of Science ®Google Scholar
• Fogarty PF , Tarantino MD , Brainsky A , et al. Selective validation of the WHO bleeding scale in patients with chronic immune thrombocytopenia. Curr Med Res Opin . 2012;28(1):79–87. doi:10.1185/03007995.2011.644849 22117897
   PubMed Web of Science ®Google Scholar
• Miller AB , Hoogstraten B , Staquet M , et al. Reporting results of cancer treatment. Cancer . 1981;47(1):207–214. doi:10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 7459811
   PubMed Web of Science ®Google Scholar
• Choudhry A , DeLoughery TG . Bleeding and thrombosis in acute promyelocytic leukemia. Am J Hematol . 2012;87(6):596–603. doi:10.1002/ajh.23158 22549696
   PubMed Web of Science ®Google Scholar